Article Text

Download PDFPDF
Anti-thrombopoietin antibodies suppress megakaryocytic colony formation in vitro in patients with systemic lupus erythaematosus
  1. P D Ziakas,
  2. H A Papadaki,
  3. M Psyllaki2,
  4. M Voulgarelis1
  1. 1
    Department of Pathophysiology, Medical School, National University of Athens, Athens, Greece
  2. 2
    Department of Haematology of the University of Crete School of Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece
  1. Michael Voulgarelis, Department of Pathophysiology, Medical School, University of Athens, 75 M. Asias Street, Goudi, 115 27, Athens, Greece; mvoulgar{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Autoantibodies against thrombopoietin (TPO) have been implicated in systemic lupus erythaematosus (SLE) thrombocytopoenia.1 2 To investigate their pathophysiological significance, we have evaluated the effect of SLE sera on megakaryocytic colony formation in vitro.

A total of 35 randomly selected SLE sera were initially screened for the presence of antiplatelet antibodies (APAs), using a commercially available assay (PAK12, GTI Diagnostics, Wauksesha, Wisconsin, USA). In all, 16 sera tested positive and were excluded from the analysis. Only sera negative for APAs have been evaluated in the current study, since APAs have been reported to inhibit megakaryopoiesis in vitro.3 Of the remaining 19 samples, 7 tested positive for anti-TPO antibodies and 12 were negative. TPO concentration was then measured by a …

View Full Text


  • Competing interests: None declared.